Table 4.

Multivariate Logistic Regression Analysis for Clinically Meaningful Outcome Represented by Mean MAL QOM Scale (≥3)

	At 2 Weeks (Immediate Posttreatment)				At 12 Months
Variables	Estimate (β)	Standard Error	Wald Chi-Square	P Value	Estimate (β)	Standard Error	Wald Chi-Square	P Value
Age	NS				−0.0331	0.0171	3.7311	.0534
Gender (1 = female)	0.1739	0.5363	0.1052	.7457	0.1088	0.4642	0.0549	.8147
Dominant side (1 = left)	−0.3743	0.7951	0.2216	.6378	0.3300	0.7241	0.2077	.6486
Side of stroke (1 = left)	−0.3307	0.5291	0.3906	.5320	−0.3682	0.4336	0.7211	.3958
Functional level (1 = high)	0.9311	1.2428	0.5612	.4538	−0.0167	0.7254	0.0005	.9817
Group (1 = treatment)	2.4704	0.6283	15.4616	<.0001	1.2770	0.4688	7.4211	.0064
Pretreatment mean MAL QOM	1.9039	0.4267	19.9087	<.0001	1.6442	0.3602	20.8349	<.0001
Pretreatment log mean WMFT time	−1.1863	0.3844	9.5250	.0020	−0.5758	0.2941	3.8322	.0503
Pretreatment FMA motor	0.0722	0.0306	5.5758	.0182	NS
Sensory impairment (proprioception)	NS				−1.6322	0.5658	8.3226	.0039
Intercept	−7.6668	2.4259	9.9878	.0016	−0.7780	1.4947	0.2709	.6027
−2 Log Likelihood		106.440				145.941
Hosmer & Lemeshow	Chi-Square 8 df = 8.9196, P = .3491				Chi-Square 8 df = 14.8659, P = .0618
Goodness-of-Fit

MAL QOM = Motor Activity Log Quality of Movement; WMFT = Wolf Motor Function Test; FMA = Fugl-Meyer Assessment.